2Li JY,Ershow AG,Chen ZJ,et al.A case control study of cancer of the esophageal and gastric cardia in Linxian.Int J Cancer,1989,43(5):755.
3Choi SW,Mason JB.Folate and carcinogenesis:an integrated scheme.J Nutr,2000,130(2):129.
4Mayne ST,Risch HA,Dubrow R,et al.Nutrient intake and risk of subtypes of esophageal and gastric cancer.Cancer Epidemiol Biomark Prev,2001,10(10):1055.
5Song C,Xing D,Tan W,et al.Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.Cancer Res,2001,61(8):3272.
6Miao X,Xing D,Tan W,et al.Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk chinese population.Cancer Epidemiol Biomarkers Prey,2002,11 (11):1454.
7Shen H,Xu Y,Zheng Y,et al.Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population:a case-control study.Int J Cancer,2001,95(5):332.
8Luo HR,Lu XM,Yao YG,et al.Length polymorphism of thymidylate synthase regulatory region in Chinese populations and evolution of the novel alleles.Biochem Genet,2002,40(1-2):41.
9Marsh S,Collie Duguid ES,Li T,et al.Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations.Genomics,1999,58(3):310.
10Gudnason V,Stansbie D,Scott J,et al.C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR):its frequency and impact on plasma homocysteine concentration in different European populations.EARS group.Atherosclerosis,1998,136 (2):347.
